Viewing Study NCT04779892


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-25 @ 2:48 PM
Study NCT ID: NCT04779892
Status: COMPLETED
Last Update Posted: 2021-10-11
First Post: 2021-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety
Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module